Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the ...

According to a filing with the Securities and Exchange Commission released on Tuesday, Lane Generational sold its entire ...

Q3 2025 Earnings Call Transcript November 3, 2025 Bruker Corporation beats earnings expectations. Reported EPS is $0.6, ...

Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying ...

With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ:BRKR) develops and ...

Bruker’s stock price target has recently seen a slight uptick, with consensus analyst forecasts rising from $46.73 to $47.82. This modest increase signals renewed analyst confidence in the company’s ...

Despite a dip in revenue and earnings, Bruker Corp (BRKR) focuses on innovation and cost-saving measures to drive future ...

Analysts are estimating that Bruker will report an earnings per share (EPS) of $0.33. Bruker bulls will hope to hear the ...

Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors ("Board") has approved payment of a ...

Bruker’s MALDI Biotyper CA System wins FDA clearance for new software, faster workflows and 549 validated species.

NYSBC has placed an order for the first Multifield NMR Relaxometry System in North America. In contrast, NSF funding has been ...

BALTIMORE--(BUSINESS WIRE)-- At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ...